# A Study to Compare Two Tablet Formulations of Study Medicine Atirmociclib in Healthy Participants

> **NCT07130097** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 35 (actual)

## Conditions studied

- Healthy Participant

## Interventions

- **DRUG:** PF-07220060

## Key facts

- **NCT ID:** NCT07130097
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-08-14
- **Primary completion:** 2025-10-26
- **Final completion:** 2025-11-18
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2026-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07130097

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07130097, "A Study to Compare Two Tablet Formulations of Study Medicine Atirmociclib in Healthy Participants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07130097. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*